FCA
BNTX icon

FinTrust Capital Advisors’s BioNTech BNTX Stock Holding History

FinTrust Capital Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-65
Closed -$5.22K – 1386
2024
Q2 		$5.22K Hold
65
– – ﹤0.01% 1038
2024
Q1 		$6K Hold
65
– – ﹤0.01% 953
2023
Q4 		$6.86K Buy
+65
New +$6.55K ﹤0.01% 892

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FinTrust Capital Advisors's BNTX Position: Q3 2024 in Review

FinTrust Capital Advisors sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 65 shares — an estimated $5.22K sold.

FinTrust Capital Advisors first reported a position in BNTX in Q4 2023 and held it in 3 quarters. The position peaked at $6.86K in Q4 2023. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • FinTrust Capital Advisors reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • FinTrust Capital Advisors sold 65 BioNTech shares in Q3 2024, an estimated $5.22K.
  • FinTrust Capital Advisors first reported a position in BioNTech in Q4 2023 and held it in 3 quarters.
  • FinTrust Capital Advisors's BioNTech position peaked at $6.86K in Q4 2023.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.